Dr. Alberto Lopez, M.D.
What this data tells you about Dr. Lopez
Dr. Alberto Lopez is a cardiovascular disease in Houston, TX, with 19 years in practice. Based on federal Medicare data, Dr. Lopez performed 5,262 Medicare services across 3,428 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lopez received a total of $26,145 from 39 pharmaceutical and/or device companies across 458 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lopez is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Regadenoson injection (Lexiscan) for heart stress test | 1,324 | $46 | $73 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 526 | $53 | $143 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 522 | $207 | $267 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 479 | $1,929 | $2,998 |
| Nuclear medicine study of heart muscle blood flow by pet | 478 | $145 | $226 |
| Electrocardiogram (EKG), 12-lead | 358 | $11 | $33 |
| Office visit, established patient (30-39 min) | 271 | $94 | $168 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 270 | $19 | $35 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 259 | $30 | $48 |
| Remote pacemaker monitoring, 90 days | 249 | $22 | $57 |
| Office visit, established patient (20-29 min) | 108 | $67 | $119 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 86 | $26 | $101 |
| Remote pacemaker/defibrillator monitoring, 90 days | 54 | $18 | $58 |
| Office visit, established patient, complex (40-54 min) | 47 | $138 | $235 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 45 | $74 | $115 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 44 | $340 | $993 |
| Chest X-ray, 2 views | 34 | $26 | $47 |
| Programming of dual lead pacemaker system | 24 | $56 | $100 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 20 | $773 | $1,367 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 17 | $418 | $648 |
| Heart rhythm recording of continous external ekg over 8-15 days | 16 | $9 | $20 |
| Hospital discharge day management, 30 minutes or less | 16 | $65 | $87 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 15 | $21 | $35 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (58%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lopez is a cardiac & remote specialist, with above-average Medicare volume (top 15% in TX), and high industry engagement (speaking/promotional, top 16%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lopez experienced with regadenoson injection (lexiscan) for heart stress test?
Does Dr. Lopez receive payments from pharmaceutical companies?
How do Dr. Lopez's costs compare to other cardiovascular diseases in Houston?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology